Arcus Biosciences (RCUS) Non-Current Assets (2017 - 2026)

Arcus Biosciences' Non-Current Assets history runs 10 years deep, the most recent figure standing at $153.0 million for Q1 2026.

• In Q1 2026, Non-Current Assets fell 9.47% year-over-year to $153.0 million; the TTM figure through Mar 2026 stood at $531.0 million (down 18.81% YoY), while the FY2025 annual figure was $132.0 million, down 1.49% from the prior year.
• Non-Current Assets was $153.0 million for Q1 2026 at Arcus Biosciences, up from $132.0 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $309.0 million in Q3 2023 to a low of $117.0 million in Q3 2025.
• Historically, Non-Current Assets has averaged $207.1 million across 5 years, with a median of $233.0 million in 2022.
• The sharpest annual moves came in 2022 and 2024: Non-Current Assets jumped 199.41% in 2022, then sank 49.24% in 2024.
• A 5-year view of Non-Current Assets shows it stood at $233.0 million in 2022, then grew by 13.3% to $264.0 million in 2023, then tumbled by 49.24% to $134.0 million in 2024, then declined by 1.49% to $132.0 million in 2025, then increased by 15.91% to $153.0 million in 2026.
• The last three Non-Current Assets figures came in at $153.0 million (Q1 2026), $132.0 million (Q4 2025), and $117.0 million (Q3 2025), per Business Quant data.